In one paragraphArticle in Biochemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Jaroslawna MeisterMolecular Signaling Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland 20892, United States.
Lizzy WankaInstitute of Biochemistry, Faculty of Life Sciences, Leipzig University, Leipzig 04109, Germany.
Nicole A Perry-HauserDepartment of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States.
Liu LiuMolecular Signaling Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland 20892, United States.
Tina M IversonDepartment of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States.ORCID 0000-0001-8816-6352 Vsevolod V GurevichDepartment of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States.ORCID 0000-0002-3950-5351 Annette G Beck-SickingerInstitute of Biochemistry, Faculty of Life Sciences, Leipzig University, Leipzig 04109, Germany.ORCID 0000-0003-4560-8020 Andrew C KruseDepartment of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts 02115, United States.ORCID 0000-0002-1467-1222 Jürgen WessMolecular Signaling Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland 20892, United States.ORCID 0000-0003-0818-1232 Funding
Molecular basis for arrestin-mediated signalingR01GM120569 · NIGMS · VANDERBILT UNIVERSITY · PI T M Iverson · 2016 to 2026
$1.9MMolecular basis of G protein-coupled receptor functionZ01DK031129 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI WESS, JURGEN · 2007 to 2008
$832kIntramural NIH HHS Z01 DK031129NIGMS NIH HHS R01 GM120569
6 · The paper itselfAbstract
Indexed as
beta-ArrestinsGTP-Binding ProteinsReceptor, Muscarinic M3AnimalsCHO CellsCricetulusHEK293 CellsHumansMiceMutationSignal Transductionbeta-ArrestinsGTP-Binding ProteinsReceptor, Muscarinic M3
Identifiers
PMID40489785
PMCPMC13005129
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390